Sigilon Therapeutics, Inc. (SGTX)

Not featured in screeners

Not featured in screeners

Ticker: SGTX Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Sigilon Therapeutics, Inc.

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

1.5

ELI LILLY & Co Large shareholder

Transaction date 11 Aug 2023

Purchase

Price

293.20

Quantity 88,597 +49.2%

Value US$3,904,546

Comments Filing

ANDERSON DANIEL GRIFFITH Non-Executive Director

Transaction date 2 Jun 2021

Sale

Price

61.04

Quantity 5,672 +27.0%

Value US$3,642,444

1.5

ELI LILLY & Co Large shareholder

Transaction date 8 Dec 2020

Purchase

Price

150.21

Quantity 34,828 +27.7%

Value US$836,688

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-08-14	2023-08-11	B Purchase	1.5 ELI LILLY & Co Large shareholder	88,597 +49.2% 293.20 US$3,904,546	88,597 +49.2%	293.20	US$3,904,546
2021-06-04	2021-06-02	S Sale	ANDERSON DANIEL GRIFFITH Non-Executive Director	5,672 +27.0% 61.04 US$3,642,444	5,672 +27.0%	61.04	US$3,642,444
2020-12-10	2020-12-08	B Purchase	1.5 ELI LILLY & Co Large shareholder	34,828 +27.7% 150.21 US$836,688	34,828 +27.7%	150.21	US$836,688